Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009

J Invest Dermatol. 2014 Apr;134(4):1141-1142. doi: 10.1038/jid.2013.464. Epub 2013 Nov 11.

Authors

Sultan A Mirzoyev¹, Adam G Schrum², Mark D P Davis¹, Rochelle R Torgerson³

Affiliations

¹ Division of Clinical Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Immunology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Division of Clinical Dermatology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Torgerson.rochelle@mayo.edu.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Alopecia Areata / diagnosis
Alopecia Areata / epidemiology*
Child
Child, Preschool
Databases, Factual
Female
Humans
Incidence
Infant
Infant, Newborn
Male
Middle Aged
Minnesota / epidemiology
Registries
Risk
Sex Factors
Young Adult

Grants and funding